Mimotopes PTY LTD.
Mimotopes Pty Ltd, established in Melbourne, Australia in 1988, is recognized as one
of the first combinatorial chemistry companies formed and an industry leader in the peptide
and discovery chemistry sector. The pioneering work of Dr. Mario Geysen enabled the parallel
synthesis of peptides and subsequently small molecules to become mainstream.
Mimotopes develops, markets and distributes sophisticated biochemical products
and services for the biotech and pharmaceutical industries. Mimotopes uses proprietary
technologies in solid phase synthesis, molecule scavenging applications and biomolecular
capture and immobilisation. Mimotopes’ expertise in polymer chemistry has enabled it to
launched the most respected and advanced solid phase synthesis platforms for solid phase
synthesis of drug-like molecules (SynPhaseTM Lanterns). Mimotopes is the preeminent
epitope mapping company covering all forms of B- and T-cell epitope mapping for drug
discovery and vaccine research making important contributions in developing diagnostics
and vaccine candidates.